[
  {
    "ts": null,
    "headline": "Artisan Mid Cap Value Fund Q2 2025 Commentary",
    "summary": "Equity markets in Q2 were marked by significant volatility, driven primarily by the announcement and subsequent pause of the so-called Liberation Day tariffs. Read more here.",
    "url": "https://finnhub.io/api/news?id=7a52a2e6863f88e4dca490c656f9559a3f32cbd2f02fa1d693e3e5b24cc2df42",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755128400,
      "headline": "Artisan Mid Cap Value Fund Q2 2025 Commentary",
      "id": 136342938,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1990349798/image_1990349798.jpg?io=getty-c-w1536",
      "related": "ALGN",
      "source": "SeekingAlpha",
      "summary": "Equity markets in Q2 were marked by significant volatility, driven primarily by the announcement and subsequent pause of the so-called Liberation Day tariffs. Read more here.",
      "url": "https://finnhub.io/api/news?id=7a52a2e6863f88e4dca490c656f9559a3f32cbd2f02fa1d693e3e5b24cc2df42"
    }
  },
  {
    "ts": null,
    "headline": "Biogen, Moderna, Align Technology, QuidelOrtho, and Masimo Shares Skyrocket, What You Need To Know",
    "summary": "A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Price Index (CPI) report, investors are increasingly betting on a rate reduction next month, a sentiment amplified by U.S. Treasury Secretary Scott Bessent's call for a significant cut. This has fueled a 'risk-on' environment across Wall Street. Lower interest rates are typically beneficial for growth",
    "url": "https://finnhub.io/api/news?id=f748b6a3dc571de13eb1fedaabf19603761a479b602748cb464eeb611f0c9cde",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755121846,
      "headline": "Biogen, Moderna, Align Technology, QuidelOrtho, and Masimo Shares Skyrocket, What You Need To Know",
      "id": 136342003,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ALGN",
      "source": "Yahoo",
      "summary": "A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Price Index (CPI) report, investors are increasingly betting on a rate reduction next month, a sentiment amplified by U.S. Treasury Secretary Scott Bessent's call for a significant cut. This has fueled a 'risk-on' environment across Wall Street. Lower interest rates are typically beneficial for growth",
      "url": "https://finnhub.io/api/news?id=f748b6a3dc571de13eb1fedaabf19603761a479b602748cb464eeb611f0c9cde"
    }
  },
  {
    "ts": null,
    "headline": "Align Technology (ALGN) Announces $200 Million Open Market Stock Repurchase",
    "summary": "Align Technology, Inc. (NASDAQ:ALGN) is one of the best falling stocks to buy now. On August 5, the company announced plans to buy back $200 million of its common stock through open-market transactions. This repurchase is part of Align’s broader $1.0 billion stock repurchase program, which the Board approved in April this year. The company […]",
    "url": "https://finnhub.io/api/news?id=e9feba94f21dd5b92917eb566d57bc6844ca93ae363243a8a4d9ce450aecf985",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755113553,
      "headline": "Align Technology (ALGN) Announces $200 Million Open Market Stock Repurchase",
      "id": 136345220,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ALGN",
      "source": "Yahoo",
      "summary": "Align Technology, Inc. (NASDAQ:ALGN) is one of the best falling stocks to buy now. On August 5, the company announced plans to buy back $200 million of its common stock through open-market transactions. This repurchase is part of Align’s broader $1.0 billion stock repurchase program, which the Board approved in April this year. The company […]",
      "url": "https://finnhub.io/api/news?id=e9feba94f21dd5b92917eb566d57bc6844ca93ae363243a8a4d9ce450aecf985"
    }
  },
  {
    "ts": null,
    "headline": "5 Must-Read Analyst Questions From Align Technology’s Q2 Earnings Call",
    "summary": "Align Technology’s second quarter was marked by lower-than-expected revenue and profit, which led to a substantial negative market reaction. Management pointed to weaker-than-normal patient case conversion in late June, especially in North America and parts of Europe, as a key driver. CEO Joe Hogan acknowledged that “June just didn’t materialize the way we thought it would,” citing reduced patient traffic and heightened consumer reluctance to spend on elective dental procedures. Hogan also highl",
    "url": "https://finnhub.io/api/news?id=60476409a37b8375ed48e10901a0a6bfef01b2f69d3ad05530ca439599ce3571",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755058407,
      "headline": "5 Must-Read Analyst Questions From Align Technology’s Q2 Earnings Call",
      "id": 136328933,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ALGN",
      "source": "Yahoo",
      "summary": "Align Technology’s second quarter was marked by lower-than-expected revenue and profit, which led to a substantial negative market reaction. Management pointed to weaker-than-normal patient case conversion in late June, especially in North America and parts of Europe, as a key driver. CEO Joe Hogan acknowledged that “June just didn’t materialize the way we thought it would,” citing reduced patient traffic and heightened consumer reluctance to spend on elective dental procedures. Hogan also highl",
      "url": "https://finnhub.io/api/news?id=60476409a37b8375ed48e10901a0a6bfef01b2f69d3ad05530ca439599ce3571"
    }
  },
  {
    "ts": null,
    "headline": "ALGN Q2 Deep Dive: Tariffs, Consumer Caution, and Restructuring Shape Outlook",
    "summary": "Dental technology company Align Technology (NASDAQ:ALGN) fell short of the market’s revenue expectations in Q2 CY2025, with sales falling 1.6% year on year to $1.01 billion. Next quarter’s revenue guidance of $975 million underwhelmed, coming in 6.4% below analysts’ estimates. Its non-GAAP profit of $2.49 per share was 3.3% below analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=9048acdbf5010e2612db740607f0f627831a5edd3789dc500ba918e4350dfd05",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755057346,
      "headline": "ALGN Q2 Deep Dive: Tariffs, Consumer Caution, and Restructuring Shape Outlook",
      "id": 136328934,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ALGN",
      "source": "Yahoo",
      "summary": "Dental technology company Align Technology (NASDAQ:ALGN) fell short of the market’s revenue expectations in Q2 CY2025, with sales falling 1.6% year on year to $1.01 billion. Next quarter’s revenue guidance of $975 million underwhelmed, coming in 6.4% below analysts’ estimates. Its non-GAAP profit of $2.49 per share was 3.3% below analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=9048acdbf5010e2612db740607f0f627831a5edd3789dc500ba918e4350dfd05"
    }
  }
]